Panbela Therapeutics, Inc.
USD0.01
+0.00 (+0.00%)
CEO
Jennifer K. Simpson
IPO Date
2017-01-03
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.02
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.02
52W Low
$0.00
52W High
$2.50
Market Cap
$0.00B
Volume
0.00M
| 72,800 |
| $0.39 |
| 13 Nov 2023 | GOLDMAN SACHS GROUP INC | 10 percent owner | S-Sale | Disposed | 72,874 | $0.71 |
| 13 Nov 2023 | GOLDMAN SACHS GROUP INC | 10 percent owner | Disposed | 0 | $0.00 |
| 29 Mar 2023 | Fratamico Arthur | director | A-Award | Acquired | 8,333 | $0.50 |
| 29 Mar 2023 | MATHIESEN JEFFREY S | director | A-Award | Acquired | 8,333 | $0.50 |
| 29 Mar 2023 | Horvath Susan | V.P. of Finance & CFO | A-Award | Acquired | 34,369 | $0.50 |
| 29 Mar 2023 | Schemel Donald Robert | director, 10 percent owner: | A-Award | Acquired | 8,333 | $0.50 |
| 29 Mar 2023 | Cullen Michael T. | director, 10 percent owner: | A-Award | Acquired | 8,333 | $0.50 |
| 29 Mar 2023 | Simpson Jennifer K. | director, officer: President and CEO | A-Award | Acquired | 99,383 | $0.50 |